[HTML][HTML] Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation

AJ Kombe Kombe, B Li, A Zahid, HM Mengist… - Frontiers in public …, 2021 - frontiersin.org
Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women,
human papillomavirus (HPV) is currently the most common pathogen responsible for female …

[HTML][HTML] Next-generation vaccine platforms for COVID-19

D van Riel, E de Wit - Nature materials, 2020 - nature.com
Consensus among experts is that only an effective COVID-19 vaccine will end the
pandemic. This Comment focuses on how this pandemic has accelerated the development …

Human papillomavirus vaccination and cervical cancer risk

L Rahangdale, C Mungo, S O'Connor, CJ Chibwesha… - Bmj, 2022 - bmj.com
Persistent human papillomavirus infection is the central cause of cervical cancer, the leading
cause of cancer death among women worldwide. Clear evidence from both randomized …

[HTML][HTML] Vaccine hesitancy in migrant communities: a rapid review of latest evidence

AS Tankwanchi, B Bowman, M Garrison… - Current Opinion in …, 2021 - Elsevier
Highlights•Clear evidence of vaccine hesitancy has been reported among migrant groups in
multiple countries.•Fear of measles vaccine harms intensified by anti-vaccination activism …

[HTML][HTML] Updates on HPV vaccination

O Illah, A Olaitan - Diagnostics, 2023 - mdpi.com
Cervical cancer still poses a significant global challenge. Developed countries have
mitigated this challenge by the introduction of structured screening programmes and, more …

[HTML][HTML] Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective

N Ebrahimi, Z Yousefi, G Khosravi, FE Malayeri… - Frontiers in …, 2023 - frontiersin.org
Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health
problems like genital warts and cancer. The national immunization schedules for individuals …

[HTML][HTML] Prophylactic human papillomavirus vaccination: from the origin to the current state

A Akhatova, A Azizan, K Atageldiyeva… - Vaccines, 2022 - mdpi.com
Immunization is the most successful method in preventing and controlling infectious
diseases, which has helped saving millions of lives worldwide. The discovery of the human …

Estimated prevalence and incidence of disease-associated human papillomavirus types among 15-to 59-year-olds in the United States

RM Lewis, JF Laprise, JW Gargano… - Sexually transmitted …, 2021 - journals.lww.com
Methods Prevalence and incidence were estimated for infections with any HPV (any of 37
types detected using Linear Array) and disease-associated HPV, 2 types that cause …

SARS-CoV-2 reinfection and implications for vaccine development

F Nainu, RS Abidin, MA Bahar… - Human Vaccines & …, 2020 - Taylor & Francis
ABSTRACT Coronavirus disease 2019 (COVID-19) pandemic continues to constitute a
public health emergency of international concern. Multiple vaccine candidates for COVID …

Human papillomavirus vaccination coverage, policies, and practical implementation across Europe

NH Nguyen-Huu, N Thilly, T Derrough, E Sdona… - Vaccine, 2020 - Elsevier
Background Our objectives were to describe Human Papillomavirus vaccination coverage
rates (HPV-VCR), policies, and practical steps for programme implementation that may be …